Equashield’s Jason Dutcher chats with Drug Delivery Business News editor Sarah Faulkner about the company’s closed system transfer device and its latest move to automate hazardous drug compounding.
Healthcare workers are often tasked with handling hazardous drugs, which give off harmful vapors. Exposure to these drugs has been linked to severe health risks, including infertility, miscarriage and cancer.
To guard workers against exposure to toxic compounds, Equashield has developed a streamlined closed system transfer device for the handling of hazardous drugs.
The company’s syringe unit is made up of two chambers – a liquid chamber and an air chamber – and a dual needle system. As the piston moves and the volume in one chamber increases, the other chamber decreases in volume by the same amount.
In other words, the syringe maintains constant pressure equalization inside of the vial, thereby preventing vapors or droplets from escaping into the work environment.
The medical device company touts its airtight device as being able to securely transfer drugs without leaks or escaped vapors.
In this podcast for Drug Delivery Business News, we learn about Equashield’s efforts to develop the very first robotic closed system transfer device, which the company says can complete a full day’s worth of compounding in one hour.
Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.